Apogee Therapeutics to Participate in Upcoming November Investor Conferences
30 Octobre 2023 - 1:00PM
Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage
biotechnology company advancing differentiated biologics for the
treatment of atopic dermatitis, asthma, chronic obstructive
pulmonary disease and other inflammatory and immunology
indications, today announced that management will present at the
following upcoming investor conferences:
Guggenheim Securities 5th
Annual Inflammation, Neurology & Immunology
Conference Date: Monday, November 6, 2023Time: 2:30 p.m.
ET
Stifel 2023 Healthcare ConferenceDate: Tuesday,
November 14, 2023Time: 10:20 a.m. ET
Jefferies London Healthcare ConferenceDate:
Wednesday, November 15, 2023Time: 11:30 a.m. ET
Evercore ISI 6th
Annual HealthCONx ConferenceDate: Tuesday,
November 28, 2023 Time: 11:15 a.m. ET
A live and archived webcast of the fireside chats and
presentations will be available via the News & Events page in
the Investors section of the Apogee Therapeutics website.
About Apogee Therapeutics
Apogee Therapeutics is a clinical-stage biotechnology company
seeking to develop differentiated biologics for the treatment of
atopic dermatitis (AD), asthma, chronic obstructive pulmonary
disease (COPD) and other inflammatory and immunology indications
with high unmet need. Apogee’s antibody programs are designed to
overcome limitations of existing therapies by targeting
well-established mechanisms of action and incorporating advanced
antibody engineering to optimize half-life and other properties.
The company’s two most advanced programs are APG777 and APG808,
which are being initially developed for the treatment of AD and
COPD, respectively. Based on a broad pipeline and depth of
expertise, the company believes it can deliver value and meaningful
benefit to patients underserved by today’s standard of care. For
more information, please visit www.apogeetherapeutics.com.
Investor Contacts:
Noel KurdiVP of Investor Relations Apogee
Therapeuticsnoel.kurdi@apogeetherapeutics.com
Bill SlatteryTHRUST Strategic Communications
bill@thrustsc.com
Media Contact:
Dan Budwick 1AB Mediadan@1abmedia.com
Apogee Therapeutics (NASDAQ:APGE)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Apogee Therapeutics (NASDAQ:APGE)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024